By Elaine Rigoli
Tampa, Fla., March 27 - Amnis Corp. announced Monday that it has closed its series C round of financing.
The round, originally targeted at $6 million, was significantly oversubscribed and closed with a total investment of $11.25 million, according to a news release.
Joining the initial participants in the round were CVF, LLC, the venture capital arm of the Crown family of Chicago, and MedVenture Associates of Emeryville, Calif.
Richard Robb from CVF and Annette Campbell-White from MedVenture Associates have joined the Amnis board of directors, the release said.
Amnis said it will use the proceeds to expand its commercial operations and to accelerate its strategic product development programs.
The company's flagship product, the ImageStream cell-analysis system, generates six high-resolution microscopic images of cells as they flow through the instrument at rates up to 300 cells per second, the release said.
Amnis, based in Seattle, manufactures instrumentation for the life science research and diagnostics markets.
| Issuer: | Amnis Corp.
|
| Issue: | Series C financing
|
| Amount: | $11.25 million
|
| Investors: | CVF, LLC, MedVenture Associates
|
| Announcement date: | March 27
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
